Sunzen Group Berhad

KLSE:SUNZEN Stock Report

Market Cap: RM 210.8m

Sunzen Group Berhad Management

Management criteria checks 4/4

Sunzen Group Berhad's CEO is Yek Teo, appointed in Jun 2020, has a tenure of 5.5 years. total yearly compensation is MYR365.33K, comprised of 82.1% salary and 17.9% bonuses, including company stock and options. directly owns 14.9% of the company’s shares, worth MYR31.41M. The average tenure of the management team and the board of directors is 5.5 years and 5.3 years respectively.

Key information

Yek Teo

Chief executive officer

RM 365.3k

Total compensation

CEO salary percentage82.12%
CEO tenure5.5yrs
CEO ownership14.9%
Management average tenure5.5yrs
Board average tenure5.3yrs

Recent management updates

Why We Think Sunzen Group Berhad's (KLSE:SUNZEN) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Sunzen Group Berhad's (KLSE:SUNZEN) CEO Compensation Is Not Excessive At All

Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Dec 12
Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Recent updates

Why We Think Sunzen Group Berhad's (KLSE:SUNZEN) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Sunzen Group Berhad's (KLSE:SUNZEN) CEO Compensation Is Not Excessive At All

Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Dec 12
Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise

Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Nov 07
Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations

Sunzen Biotech Berhad's (KLSE:SUNZEN) Shareholders Might Be Looking For Exit

Oct 15
Sunzen Biotech Berhad's (KLSE:SUNZEN) Shareholders Might Be Looking For Exit

Sunzen Biotech Berhad's (KLSE:SUNZEN) Returns On Capital Are Heading Higher

Aug 06
Sunzen Biotech Berhad's (KLSE:SUNZEN) Returns On Capital Are Heading Higher

If EPS Growth Is Important To You, Sunzen Biotech Berhad (KLSE:SUNZEN) Presents An Opportunity

May 25
If EPS Growth Is Important To You, Sunzen Biotech Berhad (KLSE:SUNZEN) Presents An Opportunity

Optimistic Investors Push Sunzen Biotech Berhad (KLSE:SUNZEN) Shares Up 27% But Growth Is Lacking

May 24
Optimistic Investors Push Sunzen Biotech Berhad (KLSE:SUNZEN) Shares Up 27% But Growth Is Lacking

Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price

Apr 22
Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price

Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Nov 16
What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Mar 26
Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

Dec 10
Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

CEO Compensation Analysis

How has Yek Teo's remuneration changed compared to Sunzen Group Berhad's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

RM 5m

Jun 30 2025RM 365kRM 300k

RM 3m

Jun 30 2024RM 321kRM 270k

RM 6m

Dec 31 2023n/an/a

RM 7m

Sep 30 2023n/an/a

RM 5m

Jun 30 2023n/an/a

RM 4m

Mar 31 2023n/an/a

RM 4m

Dec 31 2022RM 214kRM 175k

RM 4m

Sep 30 2022n/an/a

RM 3m

Jun 30 2022n/an/a

RM 2m

Mar 31 2022n/an/a

RM 2m

Dec 31 2021RM 148kRM 120k

RM 680k

Sep 30 2021n/an/a

-RM 9m

Jun 30 2021n/an/a

-RM 9m

Mar 31 2021n/an/a

-RM 11m

Dec 31 2020RM 74kRM 65k

-RM 13m

Compensation vs Market: Yek's total compensation ($USD88.83K) is about average for companies of similar size in the MY market ($USD112.46K).

Compensation vs Earnings: Yek's compensation has been consistent with company performance over the past year.


CEO

Yek Teo (41 yo)

5.5yrs
Tenure
RM 365,334
Compensation

Mr. Yek Ming Teo serves as Executive Director at Sunzen Group Berhad (formerly known as Sunzen Biotech Berhad) since June 16, 2020 and served as its Group Managing Director cum Group Chief Executive Office...


Leadership Team

NamePositionTenureCompensationOwnership
Chee Ching
Executive Chairman5.3yrsRM 117.81k0.54%
MYR 1.1m
Yek Teo
Group MD & Executive Director5.5yrsRM 365.33k14.9%
MYR 31.4m
Tong Phang
Chief Financial Officerno datano datano data
Wee Lim
Sales & Marketing Directorno datano datano data
Mee Teo
Company Secretary11.1yrsno datano data
Xin Goh
Company Secretaryno datano datano data
5.5yrs
Average Tenure
48.5yo
Average Age

Experienced Management: SUNZEN's management team is seasoned and experienced (5.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chee Ching
Executive Chairman5.3yrsRM 117.81k0.54%
MYR 1.1m
Yek Teo
Group MD & Executive Director5.5yrsRM 365.33k14.9%
MYR 31.4m
Yew Lee
Non Independent Non-Executive Director5.3yrsRM 79.00kno data
Kien Khoo
Independent Non-Executive Director11.4yrsRM 37.44kno data
Long Poo
Independent & Non-Executive Director2.8yrsRM 29.19k0.011%
MYR 22.8k
Aida Binti Abdullah
Senior Independent & Non Executive Director2yrsRM 61.00kno data
5.3yrs
Average Tenure
50yo
Average Age

Experienced Board: SUNZEN's board of directors are considered experienced (5.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/05 11:04
End of Day Share Price 2025/12/05 00:00
Earnings2025/09/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sunzen Group Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.